Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer

The primary endpoint of this study is to determine whether cycles of short term FMD exposure to a fasting-mimicking diet is effective in reducing total cholesterol levels.

Trial Details

NCT ID
NCT06610565
Phase
NA
Sponsor
European Institute of Oncology
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • FASTING-MIMICKING DIET PROGRAM
Locations (sample)
  • Milan, Italy, Italy|45.46427,9.18951

Key Eligibility Criteria

  • Age ≥ 18 years
  • WHO performance status score 0-2
  • Early stage breast cancer, ER positive, receiving an adjuvant endocrine treatment with aromatase inhibitor
  • Hypercholesterolemic (total cholesterol \>200mg/dL)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →